{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:06:37Z","timestamp":1771891597159,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jcv.2018.11.010","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T08:03:46Z","timestamp":1543651426000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study"],"prefix":"10.1016","volume":"110","author":[{"given":"Ibai","family":"Los-Arcos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Len","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Perello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina B.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Codina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Esperalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Sellar\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Moreso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Seron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Gavald\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2018.11.010_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0010","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir","volume":"184","author":"Razonable","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.11.010_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/tid.12227","article-title":"Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients","volume":"16","author":"Lee","year":"2014","journal-title":"Transpl. Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.jcv.2018.11.010_bib0020","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000001095","article-title":"The immunology of posttransplant CMV infection: potential effect of CMV immunoglobulins on distinct components of the immune response to CMV","volume":"100","author":"Carbone","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.11.010_bib0025","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/ajt.12401","article-title":"What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis","volume":"13","author":"Florescu","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.healun.2016.10.004","article-title":"Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: a multicenter prospective study","volume":"36","author":"Sarmiento","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2018.11.010_bib0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1432-2277.2009.00842.x","article-title":"Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States","volume":"22","author":"Schold","year":"2009","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jcv.2018.11.010_bib0045","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.11.010_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ajt.13880","article-title":"Pretransplantation donor-recipient pair seroreactivity against BK polyomavirus predicts viremia and nephropathy after kidney transplantation","volume":"17","author":"Wunderink","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK polyomavirus: clinical aspects, immune regulation, and emerging therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2018.11.010_bib0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2018.11.010_bib0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MNH.0000000000000069","article-title":"New insights in antibody-mediated rejection","volume":"23","author":"Gosset","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jcv.2018.11.010_bib0075","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2013101052","article-title":"Cytomegalovirus-responsive \u03b3\u03b4 T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions","volume":"25","author":"Bachelet","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jcv.2018.11.010_bib0080","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1182\/blood-2011-06-363655","article-title":"Antibody-dependent anti-cytomegalovirus activity of human \u03b3\u03b4 T cells expressing CD16 (Fc\u03b3RIIIa)","volume":"119","author":"Couzi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2018.11.010_bib0085","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff\u2019 05 meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2019CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff\u2019 09 meeting report: antibody mediated graft deterioration and implementation of banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff meeting report writing committee, Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Disease definitions working group of the cytomegalovirus drug development forum, definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.11.010_bib0110","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.11.010_bib0115","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1016\/j.jcv.2018.11.010_bib0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"AST Infectious Diseases Community of Practice, BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ajt.14520","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial","volume":"18","author":"Moreso","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B."},{"key":"10.1016\/j.jcv.2018.11.010_bib0135","first-page":"CD004759","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients","volume":"1","author":"Hill","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jcv.2018.11.010_bib0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.healun.2018.04.001","article-title":"Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: a multicenter prospective study","volume":"37","author":"Sarmiento","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.24078","article-title":"Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?","volume":"21","author":"Bruminhent","year":"2015","journal-title":"Liver Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0150","article-title":"Association between antibody functions and human cytomegalovirus (HCMV) replication after lung transplantation in HCMV-seropositive patients","author":"Vietzen","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.jcv.2018.11.010_bib0155","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/TP.0000000000001097","article-title":"CMV immunoglobulins for the treatment of CMV infections in thoracic transplant recipients","volume":"100","author":"Schulz","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.11.010_bib0160","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.TP.0000437671.78716.f3","article-title":"Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab","volume":"97","author":"Barbosa","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.11.010_bib0165","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/jmv.23339","article-title":"Investigation of polyomaviruses replication in pediatric patients with nephropathy receiving rituximab","volume":"84","author":"Delbue","year":"2012","journal-title":"J. Med. Virol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218302981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218302981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T23:00:41Z","timestamp":1720825241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653218302981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"alternative-id":["S1386653218302981"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2018.11.010","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2018.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}